Issue Date | Title | Type | Author(s) |
1999 | Altered Plasma and Brain Disposition and Pharmacodynamics of Methadone in Abstinent Rats | Articulo | Garrido, M.J. (María Jesús); Valle, M. (Marta); Troconiz, I.F. (Iñaki F.); Calvo, R. (Rosario) |
2012 | Application of different methods to formulate PEG-liposomes of oxaliplatin: Evaluation in vitro and in vivo | Articulo | Zalba, S. (Sara); Navarro-Blasco, I. (Iñigo); Troconiz, I.F. (Iñaki F.); Tros-de-Ilarduya, C. (Conchita); Garrido, M.J. (María Jesús) |
2015 | Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer | Articulo | Zalba, S. (Sara); Contreras, A.M. (Ana M.); Haeri, A. (Azadeh); Hagen, T.L.M. (Timo L.M.) ten; Navarro-Blasco, I. (Iñigo); Koning, G. (Gerben); Garrido, M.J. (María Jesús) |
29-Jan-2019 | Design and in vitro / in vivo evaluation of a targeted immunotherapy platform for the treatment of melanoma | Tesis | Merino-Díaz, M. (María) |
2015 | Design and in-vitro/in-vivo evaluation in colon cancer cells of targeted oxaliplatin liposomes to epidermal growth factor receptor by conjugation of different ligands | Tesis | Zalba, S. (Sara) |
7-Dec-2017 | Development of an in-vivo platform to evaluate the PK-PD relationship of an anti-PD-L1 mAb in a syngeneic mouse model of melanoma | Tesis | Contreras, A.M. (Ana M.) |
2021 | Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model | Articulo | Merino-Díaz, M. (María); Lozano-Moreda, T. (Teresa); Casares, N. (Noelia); Lana, H. (Hugo); Troconiz, I.F. (Iñaki F.); Hagen, T.L.M. (Timo L.M.) ten; Kochan, G. (Grazyna); Berraondo, P. (Pedro); Zalba, S. (Sara); Garrido, M.J. (María Jesús) |
2000 | Modeling of the In Vivo Antinociceptive Interaction between an Opioid Agonist, (+)-O-Desmethyltramadol, and a Monoamine Reuptake Inhibitor, (—)-O-Desmethyltramadol, in Rats | Articulo | Garrido, M.J. (María Jesús); Valle, M. (Marta); Campanero, M.A. (Miguel Angel); Calvo, R. (Rosario); Troconiz, I.F. (Iñaki F.) |
2000 | Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats. | Articulo | Valle, M. (Marta); Garrido, M.J. (María Jesús); Pavon, J. (Juan); Calvo, R. (Rosario); Troconiz, I.F. (Iñaki F.) |
2003 | Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: role of cytochrome P450 2D activity | Articulo | Garrido, M.J. (María Jesús); Sayar, O. (Onintza); Segura, C. (Cristina); Rapado, J. (Javier); Dios-Vieitez, M.C. (M. Carmen); Renedo, M.J. (María Jesús); Troconiz, I.F. (Iñaki F.) |
2009 | Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects: evidence for injection interval of up to 2 months | Articulo | Troconiz, I.F. (Iñaki F.); Cendros, J.M. (Josep Maria); Peraire, C. (Concepción); Ramis, J. (Joaquim); Garrido, M.J. (María Jesús); Boscani, P. (Paolo); Obach, R. (Rosendo) |
2016 | Population Pharmacokinetic Analysis of Lanreotide Autogel®/Depot in the Treatment of Neuroendocrine Tumors: Pooled Analysis of Four Clinical Trials | Articulo | Fernández-de-Trocóniz, J.I. (José Ignacio); Buil-Bruña, N (Núria); Garrido, M.J. (María Jesús); Dehez, M. (Marion); Manon, A. (Amandine); Quyen-Nguyen, T.X. (Thi Xuan); Gómez-Panzani, E.L. (Edda L.) |
2009 | Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus | Articulo | Caldés, A. (A.); Colom, H. (H.); Armendariz, Y. (Y.); Garrido, M.J. (María Jesús); Troconiz, I.F. (Iñaki F.); Gil-Vernet, S. (S.); Lloberas, N. (N.); Pou, L. (L.); Peraire, C. (Concepción); Grinyó, J.M. (J. M.) |
2020 | Quantification of pharmacokinetic profiles of PD-1/PD-L1 antibodies by validated ELISAs | Articulo | Zalba, S. (Sara); Contreras-Sandoval, A.M. (Ana M.); Martisova, E. (Eva); Debets, R. (Reno); Smerdou, C. (Cristian); Garrido, M.J. (María Jesús) |
2022 | Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria | Articulo | Fontanellas-Romá, A. (Antonio); Córdoba-Quiñones, K. M. (Karol Marcela); Serrano-Mendioroz, I. (Irantzu); Jericó-Asenjo, D. (Daniel); Merino-Díaz, M. (María); Jiang, L. (Lei); Sampedro, A. (Ana); Alegre-Esteban, M. (Manuel); Corrales, F.J. (Fernando José); Garrido, M.J. (María Jesús); Martini, P. (Paolo); Lanciego, J.L. (José Luis); Prieto, J. (Jesús); Berraondo, P. (Pedro) |